EC Number   |
Title |
Organism |
|---|
   3.1.4.1 | A novel class of tyrosyl-DNA phosphodiesterase 1 inhibitors that contains the octahydro-2H-chromen-4-ol scaffold |
Homo sapiens |
| 3.1.4.1 | Dysregulated human tyrosyl-DNA phosphodiesterase I acts as cellular toxin |
Homo sapiens |
| 3.1.4.1 | New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties |
Homo sapiens |
| 3.1.4.1 | Phosphodiesterase 1 regulation is a key mechanism in vascular aging |
Homo sapiens |
| 3.1.4.1 | Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety |
Homo sapiens |
| 3.1.4.1 | Synthesis of tyrosyl-DNA phosphodiesterase I inhibitors |
Homo sapiens |
| 3.1.4.1 | Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites |
Saccharomyces cerevisiae |
| 3.1.4.1 | Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage |
Saccharomyces cerevisiae |
| 3.1.4.1 | Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2alpha cleavage complexes in human cells |
Homo sapiens |
| 3.1.4.1 | 1,3,4-Oxadiazole-2(3H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors |
Bothrops atrox |
